View Cart  

Minimization, Omission of Risk Info Increasingly Found in Drug Promos

A A
Drug and medical device companies increasingly are minimizing or omitting the risks associated with their products in advertising and promotional materials, an FDA official says.

To View This Article:

Login

Subscribe To The Executive Briefing Series

Buy This Article Now

Add this article to your cart for $40.00